CRISPR Therapeutics AG (CRSP)
53.06
+4.13
(+8.44%)
USD |
NASDAQ |
Feb 13, 16:00
52.88
-0.18
(-0.34%)
After-Hours: 20:00
CRISPR Therapeutics Market Cap : 5.057B for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 124.71B |
| Beam Therapeutics, Inc. | 2.835B |
| Novartis AG | 311.26B |
| EvoNext Holdings SA | 7.933M |
| Kuros Biosciences Ltd. | 1.254B |
Market Cap Related Metrics
| PS Ratio | 121.03 |
| PEG Ratio | -0.0974 |
| Price to Book Value | 2.658 |
| Price | 53.06 |
| Earnings Yield | -10.52% |
| PEGY Ratio | -0.0974 |